兴科蓉医药控股有限公司（股票代码：06833）于2026年7月2日发布截至2026年6月30日止的股份变动月报表。报告显示，当月并无新增股份发行或股份回购/注销，股本结构与上月底保持一致。
报告期内，公司法定/注册股本维持在10,000,000,000股普通股，面值每股港币0.0001元，法定/注册股本总额约为港币1,000,000元。已发行股份总数依旧为2,032,890,585股，库存股数量为0股，整体股本规模与上期相比不存在变化。
公司确认已于2025年5月26日采纳并生效的购股权计划截至6月底可发行或转让203,289,058股；但报告期内并未发生任何新股发行或期权行使，亦无期权取消或失效情况。公司重申已严格遵循香港联合交易所有限公司《上市规则》及相关法规，确保已完成或正在履行所有必要程序。
公告由公司秘书彭云璐代表董事会签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.